Publication Date:
2016-03-16
Description:
We read with great interest the article by Davare et al. (1) on structural insight of ROS1 tyrosine kinase inhibitors. Non-small cell lung cancer (NSCLC) is no longer a single disease but a collection of genetically heterogeneous tumors with different therapeutic options [e.g., aberrations in EGFR, BRAF, HER2/Neu, RET, anaplastic...
Keywords:
Letters
Print ISSN:
0027-8424
Electronic ISSN:
1091-6490
Topics:
Biology
,
Medicine
,
Natural Sciences in General
Permalink